MNPHARM Molecular Farming

Welcome to MNPHARM

Molecular Farming

The Future of Animal Component Free (ACF)
Human Recombinant Protein Production

Animal Component FREE (ACF)

The world is moving towards production methods for human biomaterials that are Animal Component Free “ACF” to minimize known bacterial safety risks.

MNPHARM’s production method using plants over traditional methods, is the only method available today that is animal component free “ACF” with human-like glycosylation.

Our proteins  have minimal known bacterial safety risks and include needed human-like glycosylation.

After years of research and development, MNPHARM is positioned for growth and commercial

MNPHARM Services:

Pilot Study:

Wondering how to lower the cost of your production? Contact MNPHARM and we will work with you to lower your biomaterial and ingredient costs with our proprietary Plant-Based production system. 

Front End Construction:

Back End Finish:

  • Plant Microbial Genetic Engineering
  • Molecular Cloning
  • Gene Editing / Non-GMO
  • Gene Delivery / Transformation
  • Extraction
  • Purification (Chromatography)
  • Product Test (Cell Activity Assays, Western Blot, etc.)
  • Product Prep (Lyophilization)

Research and Development:

  • Pilot Studies / To Evaluate Feasibility
  • Product Development / Commercialization
Our services

Meet our team

Our comprehensive suite of professionals are ready to serve you.

Dave Roeser

Founder, CEO

Jeff Reinert

Founder, President

Diana Trujillo PhD

Chief Science Officer

Tom Martin

Chief Compliance Officer

FAQs

About MNPHARM?

MNPHARM SBC is a manufacturer of recombinant regenerative proteins using a proprietary method called molecular farming. We supply these proteins to researchers working on therapeutic development and are working with the B-to-B marketplace.

Why Plant Based Proteins?

Traditional methods of production take two to six months. Our plant-based expression and purification method takes only 12 days. We offer faster production and lower cost resulting in rapid therapeutic development.

Plants are Safer:  Most of the traditional methods used to produce therapeutic proteins are animal based and come with the risk of microbial contamination caused by animal bacteria. Using plants to produce protein eliminates the risk for microbial contamination.

Why MNPHARM?

MNPHARM is currently working with research organizations and various manufacturers in need of lower priced recombinant proteins. Bio-research involves repetitive testing to reach a positive conclusion. Traditional methods of protein production for testing  is very costly, time consuming and inefficient.

Will MNPHARM Make a Protein I need at a lower cost?

Yes, MNPHARM will preform a pilot study and produce your protein safer, faster, and at a lower cost.